微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 10.08% | 0.57% | -16.41% | 48/52 | 36.36% | 百奥赛图 | 74.91% | 行业排名> |
| 2025-06-30 | 12.06% | 2.27% | 34.57% | 49/52 | 36.49% | 百奥赛图 | 74.39% | 行业排名> |
| 2025-03-31 | 8.96% | -27.03% | 14.78% | 47/52 | 34.34% | *ST生物 | 64.96% | 行业排名> |
| 2024-12-31 | 7.81% | -31.81% | -22.11% | 49/52 | 35.25% | 百奥赛图 | 77.67% | 行业排名> |
| 2024-09-30 | 10.02% | -22.66% | -15% | 47/52 | 35.76% | *ST生物 | 68.03% | 行业排名> |
| 2024-06-30 | 11.79% | -18.17% | -3.98% | 48/52 | 36.65% | 百奥赛图 | 74.42% | 行业排名> |
| 2024-03-31 | 12.28% | -13.72% | 7.27% | 46/52 | 35.74% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 11.45% | 165.57% | -11.66% | 48/52 | 38.77% | 百奥赛图 | 70.59% | 行业排名> |
| 2023-09-30 | 12.96% | 55.73% | -10.05% | 47/52 | 39.87% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 14.41% | 231.32% | 1.23% | 46/52 | 39.77% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 14.23% | 195.45% | 230.17% | 45/52 | 38.93% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 4.31% | -36.01% | -48.2% | 50/52 | 40.75% | 百奥赛图 | 73.38% | 行业排名> |
| 2022-09-30 | 8.32% | -3.42% | 91.37% | 44/52 | 41.1% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 4.35% | -41.22% | -9.73% | 48/52 | 39.96% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | 4.82% | -40.84% | -28.49% | 42/52 | 38.57% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 6.74% | 75.25% | -21.82% | 50/52 | 42.48% | 药康生物 | 74.33% | 行业排名> |
| 2021-09-30 | 8.62% | 38.06% | 16.47% | 37/52 | 43.07% | *ST生物 | 84.53% | 行业排名> |
| 2021-06-30 | 7.4% | 304.24% | -9.15% | 47/52 | 42.6% | *ST生物 | 83.19% | 行业排名> |
| 2021-03-31 | 8.14% | 612.64% | 111.84% | 33/52 | 39.47% | *ST生物 | 83.9% | 行业排名> |
| 2020-12-31 | 3.84% | -51.49% | -38.42% | 47/52 | 38.51% | 成都先导 | 79.36% | 行业排名> |
| 2020-09-30 | 6.24% | -75.17% | 241.04% | 31/52 | 37.76% | 成都先导 | 75.92% | 行业排名> |
| 2020-06-30 | 1.83% | -93.71% | 215.22% | 39/52 | 39.28% | *ST生物 | 78.74% | 行业排名> |
| 2020-03-31 | -1.59% | -104.55% | -120.05% | 30/52 | 33.2% | 成都先导 | 80.82% | 行业排名> |
| 2019-12-31 | 7.92% | -78.57% | -68.48% | 48/52 | 42.94% | 成都先导 | 81.55% | 行业排名> |
| 2019-09-30 | 25.13% | -40.82% | -13.65% | 29/52 | 44.61% | 海特生物 | 84.37% | 行业排名> |
| 2019-06-30 | 29.11% | -31.43% | -16.65% | 30/52 | 45.09% | 海特生物 | 87.74% | 行业排名> |
| 2019-03-31 | 34.92% | -19.9% | -5.54% | 20/52 | 43.51% | 海特生物 | 88.04% | 行业排名> |
| 2018-12-31 | 36.97% | -7.13% | -12.95% | 33/52 | 42.09% | 海特生物 | 92.52% | 行业排名> |
| 2018-09-30 | 42.47% | 6.26% | 0.04% | 17/52 | 43.61% | 海特生物 | 94.18% | 行业排名> |
| 2018-06-30 | 42.45% | 1.88% | -2.63% | 19/52 | 43.98% | 海特生物 | 94.39% | 行业排名> |
| 2018-03-31 | 43.6% | 23.67% | 9.51% | 16/52 | 45.58% | 海特生物 | 94.57% | 行业排名> |
| 2017-12-31 | 39.81% | 2.86% | -0.39% | 23/52 | 40.94% | 退市海医 | 87.54% | 行业排名> |
| 2017-09-30 | 39.97% | 4.16% | -4.08% | 17/52 | 44.64% | 海特生物 | 95.31% | 行业排名> |
| 2017-06-30 | 41.67% | 2.23% | 18.19% | 16/52 | 43.6% | 退市海医 | 91.85% | 行业排名> |
| 2017-03-31 | 35.25% | -3.92% | -8.91% | 14/52 | 38.7% | 海特生物 | 95.45% | 行业排名> |
| 2016-12-31 | 38.7% | 15.24% | 0.87% | 18/52 | 40.43% | 退市海医 | 96.32% | 行业排名> |
| 2016-09-30 | 38.37% | 7.18% | -5.86% | 11/52 | 37.08% | 海特生物 | 95.35% | 行业排名> |
| 2016-06-30 | 40.76% | 19.5% | 11.08% | 12/52 | 33.77% | 退市海医 | 95.27% | 行业排名> |
| 2016-03-31 | 36.69% | 13.12% | 9.25% | 10/52 | 28.42% | 盈康生命 | 75.69% | 行业排名> |